Extracranial metastasis of gliobastoma: Three illustrative cases and current review of the molecular pathology and management strategies

Ray,Abhishek; Manjila,Sunil; Hdeib,Alia  M.; Radhakrishnan,Archana; Nock,Charles  J.; Cohen,Mark  L.; Sloan,Andrew  E.

doi:10.3892/mco.2015.494

Extracranial metastasis of gliobastoma: Three illustrative cases and current review of the molecular pathology and management strategies

Authors:
- Abhishek Ray
- Sunil Manjila
- Alia M. Hdeib
- Archana Radhakrishnan
- Charles J. Nock
- Mark L. Cohen
- Andrew E. Sloan
View Affiliations

Affiliations: Brain Tumor and Neuro‑Oncology Center and Department of Neurological Surgery, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA, Department of Oncology, University Hospitals Case Medical Center, Seidman Cancer Center and Case Comprehensive Cancer Center, Cleveland, OH 44106, USA, Department of Pathology, University Hospitals Case Medical Center, Seidman Cancer Center and Case Comprehensive Cancer Center, Cleveland, OH 44106, USA
Published online on: January 23, 2015 https://doi.org/10.3892/mco.2015.494
Pages: 479-486
Copyright: © Ray et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Glioblastoma (GBM) is the most common and the most malignant primary brain tumor in adults, accounting for ~12‑15% of all intracranial neoplasms. Despite advances in surgical, medical and radiation therapies, the mortality of GBM remains high, with a median survival ranging between 40 and 70 weeks. Similar to other primary brain tumors, the extracranial metastasis of GBM is extremely rare, occurring in <2% of patients. To demonstrate the clinical characteristics of this rare tumor, we herein present three cases of extracranial GBM metastasis: one to the lungs, which represents the longest reported survival of lung metastases from GBM to date; the second to the soft tissue of the posterior neck; and the third to the lumbar intradural space. Unlike tumors elsewhere, there are unique barriers in the brain that prevent the hematogenous and lymphatic spread of intracranial tumors, such as the dura mater and the thickened basement membrane of the blood vessels. In addition, central nervous system tumor cells lack extracellular matrix proteins required to invade surrounding connective tissue, a prerequisite for tumor dissemination. in this study, we aimed to investigate the different possible mechanisms underlying the extracranial metastasis of GBM and determine the biomolecular and genetic characteristics differentiating GBMs that metastasize from those that do not. We also reviewed the role of systemic chemotherapy and bevacizumab in the treatment of disseminated GBMs. Early identification and differentiation of these tumors may enable patients to benefit from surgical resection, radiation and combination chemotherapy prior to developing other comorbidities from metastatic disease, which may translate into prolonged survival with an acceptable quality of life.

View Figures

View References

1	Saad AG, Sachs J, Turner CD, et al: Extracranial metastases of glioblastoma in a child: case report and review of the literature. J Pediatr Hematol Oncol. 29:190–194. 2007. View Article : Google Scholar : PubMed/NCBI
2	Rajagopalan V, El Kamar FG, Thayaparan R and Grossbard ML: Bone marrow metastases from glioblastoma multiforme – a case report and review of the literature. J Neurooncol. 72:157–161. 2005. View Article : Google Scholar : PubMed/NCBI
3	Datta CK, Weinstein JD, Bland JE, Brager PM and Stewart MA: A case of cervical lymph node metastasis resulting from glioblastoma multiforme. W V Med J. 94:276–278. 1998.PubMed/NCBI
4	Fecteau AH, Penn I and Hanto DW: Peritoneal metastasis of intracranial glioblastoma via a ventriculoperitoneal shunt preventing organ retrieval: case report and review of the literature. Clin Transplant. 12:348–350. 1998.PubMed/NCBI
5	Piccirilli M, Brunetto GM, Rocchi G, Giangaspero F and Salvati M: Extra central nervous system metastases from cerebral glioblastoma multiforme in elderly patients. Clinico-pathological remarks on our series of seven cases and critical review of the literature. Tumori. 94:40–51. 2008.PubMed/NCBI
6	Templeton A, Hofer S, Töpfer M, et al: Extraneural spread of glioblastoma – report of two cases. Onkologie. 31:192–194. 2008. View Article : Google Scholar : PubMed/NCBI
7	Widjaja A, Mix H, Gölkel C, et al: Uncommon metastasis of a glioblastoma multiforme in liver and spleen. Digestion. 61:219–222. 2000. View Article : Google Scholar : PubMed/NCBI
8	Yasuhara T, Tamiya T, Meguro T, et al: Glioblastoma with metastasis to spleen – case report. Neurol Med Chir (Tokyo). 43:452–456. 2003. View Article : Google Scholar : PubMed/NCBI
9	Lun M, Lok E, Gautam S, Wu E and Wong ET: The natural history of extracranial metastasis from glioblastoma multiforme. J Neurooncol. 105:261–273. 2011. View Article : Google Scholar : PubMed/NCBI
10	Armanios MY, Grossman SA, Yang SC, White B, Perry A, Burger PC and Orens JB: Transmission of glioblastoma multiforme following bilateral lung transplantation from an affected donor: case study and review of the literature. Neuro Oncol. 6:259–263. 2004. View Article : Google Scholar : PubMed/NCBI
11	Chen H, Shah AS, Girgis RE and Grossman SA: Transmission of glioblastoma multiforme after bilateral lung transplantation. J Clin Oncol. 26:3284–3285. 2008. View Article : Google Scholar : PubMed/NCBI
12	Mentrikoski M, Johnson MD, Korones DN and Scott GA: Glioblastoma multiforme in skin: a report of 2 cases and review of the literature. Am J Dermatopathol. 30:381–384. 2008. View Article : Google Scholar : PubMed/NCBI
13	Bouillot-Eimer S, Loiseau H and Vital A: Subcutaneous tumoral seeding from a glioblastoma following stereotactic biopsy: case report and review of the literature. Clin Neuropathol. 24:247–251. 2005.PubMed/NCBI
14	Sloan AE, Ahluwalia MS, Valerio-Pascua J, et al: Results of the NeuroBlate System first-in-humans phase I clinical trial for recurrent glioblastoma: clinical article. J Neurosurg. 118:1202–1219. 2013. View Article : Google Scholar : PubMed/NCBI
15	Armstrong TS, Prabhu S, Aldape K, et al: A case of soft tissue metastasis from glioblastoma and review of the literature. J Neurooncol. 103:167–172. 2011. View Article : Google Scholar : PubMed/NCBI
16	Lin ZX, Yang LJ, Huang Q and Fu J: Activated vascular endothelia regulate invasion of glioma cells through expression of fibronectin. Chin Med J (Engl). 123:1754–1761. 2010.PubMed/NCBI
17	Mourad PD, Farrell L, Stamps LD, Chicoine MR and Silbergeld DL: Why are systemic glioblastoma metastases rare? Systemic and cerebral growth of mouse glioblastoma. Surg Neurol. 63:511–519. 2005. View Article : Google Scholar : PubMed/NCBI
18	Park CC, Hartmann C, Folkerth R, et al: Systemic metastasis in glioblastoma may represent the emergence of neoplastic subclones. J Neuropathol Exp Neurol. 59:1044–1050. 2000.PubMed/NCBI
19	Beaumont TL, Kupsky WJ, Barger GR and Sloan AE: Gliosarcoma with multiple extracranial metastases: case report and review of the literature. J Neurooncol. 83:39–46. 2007. View Article : Google Scholar : PubMed/NCBI
20	Maslehaty H, Cordovi S and Hefti M: Symptomatic spinal metastases of intracranial glioblastoma: clinical characteristics and pathomechanism relating to GFAP expression. J Neurooncol. 101:329–333. 2011. View Article : Google Scholar : PubMed/NCBI
21	Medhkour A and Chan M: Extremely rare glioblastoma multiforme of the conus medullaris with holocord and brain stem metastases, leading to cranial nerve deficit and respiratory failure: a case report and review of the literature. Surg Neurol. 63:576–583. 2005. View Article : Google Scholar : PubMed/NCBI
22	Vertosick FT Jr and Selker RG: Brain stem and spinal metastases of supratentorial glioblastoma multiforme: a clinical series. Neurosurgery. 27:516–522. 1990. View Article : Google Scholar : PubMed/NCBI
23	Arita N, Taneda M and Hayakawa T: Leptomeningeal dissemination of malignant gliomas. Incidence, diagnosis and outcome. Acta Neurochir (Wien). 126:84–92. 1994. View Article : Google Scholar : PubMed/NCBI
24	Onda K, Tanaka R, Takahashi H, Takeda N and Ikuta F: Cerebral glioblastoma with cerebrospinal fluid dissemination: a clinicopathological study of 14 cases examined by complete autopsy. Neurosurgery. 25:533–540. 1989. View Article : Google Scholar : PubMed/NCBI
25	Hübner F, Braun V and Richter HP: Case reports of symptomatic metastases in four patients with primary intracranial gliomas. Acta Neurochir (Wien). 143:25–29. 2001. View Article : Google Scholar : PubMed/NCBI
26	Stupp R, Mason WP, van den Bent MJ, et al: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 352:987–996. 2005. View Article : Google Scholar : PubMed/NCBI
27	Astner ST, Pihusch R, Nieder C, et al: Extensive local and systemic therapy in extraneural metastasized glioblastoma multiforme. Anticancer Res. 26:4917–4920. 2006.PubMed/NCBI
28	Steinbok P, Dolman CL and Goldie JH: Variation in response to CCNU of glioblastoma multiforme in brain and cervical lymph node. Case report. J Neurosurg. 62:918–921. 1985. View Article : Google Scholar : PubMed/NCBI
29	Brandes AA, Tosoni A, Cavallo G, et al GICNO: Temozolomide 3 weeks on and 1 week off as first-line therapy for recurrent glioblastoma: phase II study from Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO). Br J Cancer. 95:1155–1160. 2006. View Article : Google Scholar : PubMed/NCBI
30	Gaviani P, Silvani A, Lamperti E, Botturi A, Fariselli L, Simonetti G, Ferrari D and Salmaggi A: Rechallenge with temozolomide in recurrent glioma. Neurol Sci. 32:S247–S249. 2011. View Article : Google Scholar : PubMed/NCBI
31	Perry JR, Rizek P, Cashman R, Morrison M and Morrison T: Temozolomide rechallenge in recurrent malignant glioma by using a continuous temozolomide schedule: the ‘rescue’ approach. Cancer. 113:2152–2157. 2008. View Article : Google Scholar : PubMed/NCBI
32	Hegi ME, Diserens AC, Gorlia T, et al: MGMT gene silencing and benefit from temozolomide in glioblastoma. N Eng J Med. 352:997–1003. 2005. View Article : Google Scholar
33	Chamberlain MC and Johnston SK: Salvage therapy with single agent bevacizumab for recurrent glioblastoma. J Neurooncol. 96:259–269. 2010. View Article : Google Scholar : PubMed/NCBI
34	Friedman HS, Prados MD, Wen PY, et al: Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma. J Clin Oncol. 27:4733–4740. 2009. View Article : Google Scholar : PubMed/NCBI
35	Chinot OL, Wick W, Mason W, et al: Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma. N Engl J Med. 370:709–722. 2014. View Article : Google Scholar : PubMed/NCBI
36	Gilbert MR, Dignam JJ, Armstrong TS, et al: A randomized trial of bevacizumab for newly diagnosed glioblastoma. N Engl J Med. 370:699–708. 2014. View Article : Google Scholar : PubMed/NCBI
37	Wang R, Chadalavada K, Wilshire J, et al: Glioblastoma stem-like cells give rise to tumour endothelium. Nature. 468:829–833. 2010. View Article : Google Scholar : PubMed/NCBI